Robert G. Finizio

Insider Reports History

Location
Boca Raton, FL
Signature
/s/ Stephen C. Glover as Attorney-in-Fact for Robert G. Finizio pursuant to Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert G. Finizio:

Company Role Class Num Shares Value Price $ Report Date Ownership
TherapeuticsMD, Inc. CEO, Director Common Stock 17,991,637 $40,283,275 $2.24 11 May 2021 Direct
TherapeuticsMD, Inc. CEO, Director Common Stock 2,000,000 $4,478,000 $2.24 10 May 2021 Indirect
TherapeuticsMD, Inc. CEO, Director Restricted Stock Units 746,667 $2,716,449 $3.64 01 Jul 2021 Direct
TherapeuticsMD, Inc. CEO, Director Performance Stock Units 1,493,333 $2,589,439 $1.73 01 Jul 2021 Direct
ZyVersa Therapeutics, Inc. Director Stock Options 11,066 11 Jul 2025 Direct
ZyVersa Therapeutics, Inc. Director Stock Options 132 24 May 2023 Direct

Insider Reports Filed by Robert G. Finizio

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZVSA ZyVersa Therapeutics, Inc. 11 Jul 2025 1 $0 4 Director 15 Jul 2025, 16:22
ZVSA ZyVersa Therapeutics, Inc. 24 May 2023 1 $0 4 Director 18 Jul 2024, 21:35
ZVSA ZyVersa Therapeutics, Inc. 12 Dec 2022 3 $0 4 Director 14 Dec 2022, 18:40
ZVSA ZyVersa Therapeutics, Inc. 12 Dec 2022 0 $0 3 Director 13 Dec 2022, 09:46
TXMD TherapeuticsMD, Inc. 01 Jul 2021 2 $0 4 CEO, Director 02 Jul 2021, 17:54
TXMD TherapeuticsMD, Inc. 10 May 2021 3 -$70,405 4 CEO, Director 12 May 2021, 20:36